ARGYLE, TEXAS, March 25, 2021 — Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation equine regenerative products, announced today that Covetrus, a global leader in animal health technology and services, will be the exclusive distributor of...
Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation equine regenerative products, announced today that several of its sponsored riders have qualified for the Wrangler® National Finals Rodeo (NFR) 2020. This year’s event will take place in...
Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation equine regenerative products, announced today initiation of a new study evaluating use of the RenoVō® allograft in equine joints. The study, entitled “Effects of intra-articular injection of...
Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation regenerative products derived from amniotic birth tissues, announced today first results from a large field study of RenoVō® for soft tissue and orthopedic horse injuries. RenoVō® is an...
Senner and his co-founder, COO and Chief Scientific Officer, Christian Beaudry, saw a need to bring regenerative medicine to the equine world. They found the opportunity to take existing technologies and successfully apply them to the emerging branch of veterinary...
Equine Amnio Solutions, LLC (EAS), a distributor of advanced equine allografts derived from equine amniotic tissues, announced today partnership with the Oklahoma State University College of Veterinary Medicine to conduct clinical evaluation of RenoVō® on equine limb...
